Carmine Zoccali

Carmine Zoccali
Born27 January 1947 (1947-01-27) (age 77)
NationalityItalian
CitizenshipItalian
Alma materUniversity of Rome, University of Pisa
Known forCardiovascular Risk in Chronic Kidney Disease (CKD), Risk factors for CKD progression, Endothelial dysfunction and hypertension in CKD and in End Stage Kidney Disease (ESKD), Epidemiology of kidney diseases
Scientific career
FieldsNephrology, dialysis, epidemiology, hypertension, cardiovascular risk
InstitutionsCNR (National Research Council of Italy)-Clinical Physiology Institute (Clinical Epidemiology of Renal Diseases and Hypertension Unit),

Carmine Zoccali (born January 1947) is an Italian nephrologist and a clinical investigator. He has contributed to research in several fields, most notably hypertension and cardiovascular complications in chronic kidney disease (CKD), CKD progression and clinical epidemiology of kidney diseases at large. He is known for his studies on cardiovascular risk in CKD and dialysis patients. He was among the earliest investigators that focused on the relevance of endothelial dysfunction[1] and inflammation[2] for the high risk of cardiovascular disease in these populations. In this research area, he was the first to link endogenous inhibitors of the nitric oxide system with death and cardiovascular disease.[3] and the first to document a relationship between sympathetic over-activity and these outcomes[4] Dr Zoccali is a practicing specialist in Nephrology, with a national qualification for the full professorship in Nephrology. He is also a specialist in hypertension, certified by the European Society of Hypertension (ESH).[5]

  1. ^ Perticone, Francesco; Maio, Raffaele; Tripepi, Giovanni; Zoccali, Carmine (17 August 2004). "Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension". Circulation. 110 (7): 821–825. doi:10.1161/01.CIR.0000138745.21879.27. PMID 15289371. S2CID 11987668.
  2. ^ Zoccali, Carmine; Benedetto, Francesco Antonio; Mallamaci, Francesca; Tripepi, Giovanni; Fermo, Isabella; Focà, Alfredo; Paroni, Rita; Malatino, Lorenzo Salvatore (September 2000). "Inflammation is associated with carotid atherosclerosis in dialysis patients". Journal of Hypertension. 18 (9): 1207–1213. doi:10.1097/00004872-200018090-00006. PMID 10994751. S2CID 30430138.
  3. ^ Zoccali, Carmine; Bode-Böger, Stefanie M.; Mallamaci, Francesca; Benedetto, Frank Antonio; Tripepi, Giovanni; Malatino, Lorenzo Salvatore; Cataliotti, Alessandro; Bellanuova, Ignazio; Fermo, Isabella; Frölich, Jürgen C.; Böger, Rainer H. (22 December 2001). "Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study". The Lancet. 358 (9299): 2113–2117. doi:10.1016/S0140-6736(01)07217-8. PMID 11784625. S2CID 41178487.
  4. ^ Zoccali, Carmine; Mallamaci, Francesca; Parlongo, Saverio; Cutrupi, Sebastiano; Benedetto, Francesco Antonio; Tripepi, Giovanni; Bonanno, Graziella; Rapisarda, Francesco; Fatuzzo, Pasquale; Seminara, Giuseppe; Cataliotti, Alessandro; Stancanelli, Benedetta; Malatino, Lorenzo Salvatore (19 March 2002). "Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease". Circulation. 105 (11): 1354–1359. doi:10.1161/hc1102.105261. PMID 11901048. S2CID 14366282.
  5. ^ "Directory of Specialists | European Society of Hypertension | Page 45". www.eshonline.org.